Intuitive Surgical/$ISRG
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Intuitive Surgical
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
Ticker
$ISRG
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
15,638
ISIN
US46120E6023
Website
ISRG Metrics
BasicAdvanced
$195B
79.55
$6.83
1.56
-
Price and volume
Market cap
$195B
Beta
1.56
52-week high
$616.00
52-week low
$413.82
Average daily volume
1.6M
Financial strength
Current ratio
4.979
Quick ratio
3.81
Profitability
EBITDA (TTM)
2,939.125
Gross margin (TTM)
67.09%
Net profit margin (TTM)
28.41%
Operating margin (TTM)
28.44%
Effective tax rate (TTM)
11.06%
Revenue per employee (TTM)
$560,000
Management effectiveness
Return on assets (TTM)
8.84%
Return on equity (TTM)
15.96%
Valuation
Price to earnings (TTM)
79.554
Price to revenue (TTM)
22.211
Price to book
11.39
Price to tangible book (TTM)
11.52
Price to free cash flow (TTM)
110.905
Free cash flow yield (TTM)
0.90%
Free cash flow per share (TTM)
489.98%
Growth
Revenue change (TTM)
19.08%
Earnings per share change (TTM)
23.31%
3-year revenue growth (CAGR)
13.85%
10-year revenue growth (CAGR)
14.87%
3-year earnings per share growth (CAGR)
15.01%
10-year earnings per share growth (CAGR)
17.15%
What the Analysts think about ISRG
Analyst ratings (Buy, Hold, Sell) for Intuitive Surgical stock.
Bulls say / Bears say
Intuitive Surgical reported an 18% increase in global da Vinci procedures in Q4 2024, indicating strong demand for its surgical robots. (reuters.com)
The company achieved a 17% annual increase in procedure volumes for its da Vinci surgical robots in Q2 2024, surpassing revenue expectations. (reuters.com)
Analysts maintain a favorable outlook on ISRG, with 22 buy ratings, 10 hold ratings, and a minimal 1 sell rating, suggesting strong confidence in the company's growth prospects. (directorstalkinterviews.com)
Intuitive Surgical anticipates a 170 basis point gross margin headwind in 2025 due to newly implemented global tariffs, including U.S.-China trade tensions and European retaliatory tariffs. (finviz.com)
The company faces increasing competition from larger players like Johnson & Johnson and Medtronic, with Medtronic filing for FDA clearance for its Hugo robotic-assisted surgery system, potentially impacting Intuitive's market share. (finviz.com)
Intuitive Surgical's valuation is considered high, with a forward P/E ratio of 68.69, which may deter value-focused investors. (stockanalysis.com)
Data summarised monthly by Lightyear AI. Last updated on 21 Jun 2025.
ISRG Financial Performance
Revenues and expenses
ISRG Earnings Performance
Company profitability
ISRG News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Intuitive Surgical stock?
Intuitive Surgical (ISRG) has a market cap of $195B as of July 01, 2025.
What is the P/E ratio for Intuitive Surgical stock?
The price to earnings (P/E) ratio for Intuitive Surgical (ISRG) stock is 79.55 as of July 01, 2025.
Does Intuitive Surgical stock pay dividends?
No, Intuitive Surgical (ISRG) stock does not pay dividends to its shareholders as of July 01, 2025.
When is the next Intuitive Surgical dividend payment date?
Intuitive Surgical (ISRG) stock does not pay dividends to its shareholders.
What is the beta indicator for Intuitive Surgical?
Intuitive Surgical (ISRG) has a beta rating of 1.56. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.